stockrowNomura Holdings Inc ADR
Nomura Holdings Inc ADR’s revenue for fiscal 2026 (year ended March 2026) was $31.4 billion, roughly unchanged from fiscal 2025.
- Revenue
- +0.18%
- EPS
- +4.32%
- Free cash flow
- +106.2%
- Total debt
- +2.61%
Quarter to September 2026, against a year earlier
Follow NMR
Alert me
Nomura Holdings Inc ADR (NMR) EPS (diluted)
Nomura Holdings Inc ADR's EPS (diluted) for fiscal 2026 was $0.79, up 8.22% from $0.73 in fiscal 2025. Over the twelve months to 30 September 2026 it was $0.99. Over the past ten years it has ranged from −$0.27 (fiscal 2019) to $0.79 (fiscal 2026) — the current reading is the highest in ten years. EPS (diluted) has risen for 3 consecutive fiscal years. Nomura Holdings Inc ADR ranks 28th of 83 Capital Markets companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2026 | $0.79 | 8.22% |
| FY2025 | $0.73 | 102.78% |
| FY2024 | $0.36 | 63.64% |
| FY2023 | $0.22 | (47.62%) |
| FY2022 | $0.42 | (8.70%) |
| FY2021 | $0.46 | (25.81%) |
| FY2020 | $0.62 | — |
| FY2019 | −$0.27 | — |
| FY2018 | $0.57 | (6.56%) |
| FY2017 | $0.61 | 90.74% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $0.23 | (23.50%) |
| Jun 2026 | $0.30 | 36.36% |
| Sep 2025 | $0.22 | (8.33%) |
| Jun 2025 | $0.24 | 9.09% |
| 39 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| EVR Evercore Inc compare | $18.61 |
| LPLA LPL Financial Holdings Inc. compare | $17.43 |
| SF Stifel Financial Corporation compare | $5.76 |
| TW Tradeweb Markets Inc. compare | $4.39 |
| JEF Jefferies Financial Group Inc. compare | $3.75 |
| IBKR Interactive Brokers Group, Inc. compare | $2.60 |
| CRCL Circle Internet Group, Inc. compare | $1.66 |
| NMR Nomura Holdings Inc ADR | $0.99 |
| BMNR BitMine Immersion Technologies, Inc. compare | −$20.89 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on NMR
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- The full statement